Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 18-Sep-24 4:15 PM View:  | Bailey John E. (jack) Jr. President and CEO Director | G1 Therapeutics, Inc. (GTHX) | 18-Sep-24 | Grant | 181,400 | -- | -- | 33% 549.67K to 731.07K | |
| 18-Sep-24 4:15 PM View: | Thomas Monica R. Chief Legal & People Officer | G1 Therapeutics, Inc. (GTHX) | 18-Sep-24 | Disposition (change in control) | 6,674 | -- | -- | (100%) 6.67K to 0 | |
| 18-Sep-24 4:15 PM View: | Nicholson Garry A Director | G1 Therapeutics, Inc. (GTHX) | 18-Sep-24 | Disposition | 20,000 | -- | -- | (58%) 34.39K to 14.39K | |
| 18-Sep-24 4:15 PM View: | Malik Rajesh Chief Medical Officer | G1 Therapeutics, Inc. (GTHX) | 18-Sep-24 | Grant | 17,900 | -- | -- | 11% 159.31K to 177.21K | |
| 18-Sep-24 4:15 PM View: | Perry Andrew Chief Commercial Officer | G1 Therapeutics, Inc. (GTHX) | 18-Sep-24 | Disposition (change in control) | 14,232 | -- | -- | (100%) 14.23K to 0 | |
| 18-Sep-24 4:15 PM View: | Lee Jacks Director | G1 Therapeutics, Inc. (GTHX) | 18-Sep-24 | Disposition | 10,000 | -- | -- | (50%) 20.0K to 10.0K | |
| 18-Sep-24 4:15 PM View: | Avagliano Mark Chief Business Officer | G1 Therapeutics, Inc. (GTHX) | 18-Sep-24 | Grant | 20,600 | -- | -- | 9% 242.04K to 262.64K | |
| 18-Sep-24 4:15 PM View: | Muir Glenn P Director | G1 Therapeutics, Inc. (GTHX) | 18-Sep-24 | Disposition | 20,000 | -- | -- | (10%) 205.36K to 185.36K | |
| 18-Sep-24 4:15 PM View: | Murdock Terry L Chief Operating Officer | G1 Therapeutics, Inc. (GTHX) | 18-Sep-24 | Disposition | 124,762 | -- | -- | (86%) 145.91K to 21.15K | |
| 18-Sep-24 4:15 PM View: | Secor Alicia Director | G1 Therapeutics, Inc. (GTHX) | 18-Sep-24 | Disposition | 20,000 | -- | -- | (67%) 30.0K to 10.0K | |
| 18-Sep-24 4:15 PM View: | Umstead John V. Chief Financial Officer | G1 Therapeutics, Inc. (GTHX) | 18-Sep-24 | Disposition | 168,387 | -- | -- | (90%) 187.72K to 19.33K | |
| 18-Sep-24 4:15 PM View: | Bailey John E. (jack) Jr. President and CEO Director | G1 Therapeutics, Inc. (GTHX) | 18-Sep-24 | Disposition | 534,787 | -- | -- | (73%) 731.07K to 196.29K | |
| 18-Sep-24 4:15 PM View: | Nicholson Garry A Director | G1 Therapeutics, Inc. (GTHX) | 18-Sep-24 | Disposition (change in control) | 14,389 | -- | -- | (100%) 14.39K to 0 | |
| 18-Sep-24 4:15 PM View: | Malik Rajesh Chief Medical Officer | G1 Therapeutics, Inc. (GTHX) | 18-Sep-24 | Disposition | 89,762 | -- | -- | (51%) 177.21K to 87.45K | |
| 18-Sep-24 4:15 PM View: | Perry Andrew Chief Commercial Officer | G1 Therapeutics, Inc. (GTHX) | 18-Sep-24 | Grant | 16,100 | -- | -- | 14% 112.61K to 128.71K | |
| 18-Sep-24 4:15 PM View: | Lee Jacks Director | G1 Therapeutics, Inc. (GTHX) | 18-Sep-24 | Disposition (change in control) | 10,000 | -- | -- | (100%) 10.0K to 0 | |
| 18-Sep-24 4:15 PM View: | Avagliano Mark Chief Business Officer | G1 Therapeutics, Inc. (GTHX) | 18-Sep-24 | Disposition | 236,610 | -- | -- | (90%) 262.64K to 26.04K | |
| 18-Sep-24 4:15 PM View: | Sharpless Norman Director | G1 Therapeutics, Inc. (GTHX) | 18-Sep-24 | Disposition | 20,000 | -- | -- | (100%) 20.0K to 0 | |
| 18-Sep-24 4:15 PM View: | Muir Glenn P Director | G1 Therapeutics, Inc. (GTHX) | 18-Sep-24 | Disposition (change in control) | 185,358 | -- | -- | (100%) 185.36K to 0 | |
| 18-Sep-24 4:15 PM View: | Schwalm Cynthia Director | G1 Therapeutics, Inc. (GTHX) | 18-Sep-24 | Disposition | 20,000 | -- | -- | (56%) 35.89K to 15.89K | |
| 18-Sep-24 4:15 PM View: | Murdock Terry L Chief Operating Officer | G1 Therapeutics, Inc. (GTHX) | 18-Sep-24 | Disposition (change in control) | 21,150 | -- | -- | (100%) 21.15K to 0 | |
| 18-Sep-24 4:15 PM View: | Secor Alicia Director | G1 Therapeutics, Inc. (GTHX) | 18-Sep-24 | Disposition (change in control) | 10,000 | -- | -- | (100%) 10.0K to 0 | |
| 18-Sep-24 4:15 PM View: | Umstead John V. Chief Financial Officer | G1 Therapeutics, Inc. (GTHX) | 18-Sep-24 | Disposition (change in control) | 19,331 | -- | -- | (100%) 19.33K to 0 | |
| 18-Sep-24 4:15 PM View: | Thomas Monica R. Chief Legal & People Officer | G1 Therapeutics, Inc. (GTHX) | 18-Sep-24 | Disposition | 138,151 | -- | -- | (95%) 144.82K to 6.67K | |
| 18-Sep-24 4:15 PM View: | Bailey John E. (jack) Jr. President and CEO Director | G1 Therapeutics, Inc. (GTHX) | 18-Sep-24 | Disposition (change in control) | 196,287 | -- | -- | (100%) 196.29K to 0 | |
| 18-Sep-24 4:15 PM View: | Malik Rajesh Chief Medical Officer | G1 Therapeutics, Inc. (GTHX) | 18-Sep-24 | Disposition (change in control) | 87,450 | -- | -- | (100%) 87.45K to 0 | |
| 18-Sep-24 4:15 PM View: | Perry Andrew Chief Commercial Officer | G1 Therapeutics, Inc. (GTHX) | 18-Sep-24 | Disposition | 114,482 | -- | -- | (89%) 128.71K to 14.23K | |
| 18-Sep-24 4:15 PM View: | Avagliano Mark Chief Business Officer | G1 Therapeutics, Inc. (GTHX) | 18-Sep-24 | Disposition (change in control) | 26,035 | -- | -- | (100%) 26.04K to 0 | |
| 18-Sep-24 4:15 PM View: | Schwalm Cynthia Director | G1 Therapeutics, Inc. (GTHX) | 18-Sep-24 | Disposition (change in control) | 15,889 | -- | -- | (100%) 15.89K to 0 | |
| 18-Sep-24 4:15 PM View: | Murdock Terry L Chief Operating Officer | G1 Therapeutics, Inc. (GTHX) | 18-Sep-24 | Grant | 17,900 | -- | -- | 14% 128.01K to 145.91K | |
| 08-Jul-24 5:54 PM View: | Umstead John V. Chief Financial Officer | G1 Therapeutics, Inc. (GTHX) | 05-Jul-24 | Sale | 527 | $2.51 | $1,321.56 | (< 1%) 188.25K to 187.72K | |
| 08-Jul-24 5:59 PM View: | Perry Andrew Chief Commercial Officer | G1 Therapeutics, Inc. (GTHX) | 05-Jul-24 | Sale | 1,337 | $2.51 | $3,352.79 | (1%) 113.95K to 112.61K | |
| 08-Jul-24 5:58 PM View: | Murdock Terry L Chief Operating Officer | G1 Therapeutics, Inc. (GTHX) | 05-Jul-24 | Sale | 2,475 | $2.51 | $6,206.56 | (2%) 130.49K to 128.01K | |
| 08-Jul-24 5:53 PM View: | Bailey John E. (jack) Jr. President and CEO Director | G1 Therapeutics, Inc. (GTHX) | 05-Jul-24 | Sale | 7,662 | $2.51 | $19,214.00 | (1%) 557.34K to 549.67K | |
| 08-Jul-24 5:57 PM View: | Malik Rajesh Chief Medical Officer | G1 Therapeutics, Inc. (GTHX) | 05-Jul-24 | Sale | 2,475 | $2.51 | $6,206.56 | (2%) 161.79K to 159.31K | |
| 08-Jul-24 5:55 PM View: | Avagliano Mark Chief Business Officer | G1 Therapeutics, Inc. (GTHX) | 05-Jul-24 | Sale | 2,638 | $2.51 | $6,615.31 | (1%) 244.68K to 242.04K | |
| 03-Jul-24 5:27 PM View: | Thomas Monica R. Chief Legal & People Officer | G1 Therapeutics, Inc. (GTHX) | 01-Jul-24 | Grant | 35,000 | -- | -- | 32% 109.83K to 144.82K | |
| 03-Jul-24 5:32 PM View: | Murdock Terry L Chief Operating Officer | G1 Therapeutics, Inc. (GTHX) | 01-Jul-24 | Grant | 35,000 | -- | -- | 37% 95.49K to 130.49K | |
| 03-Jul-24 5:22 PM View: | Bailey John E. (jack) Jr. President and CEO Director | G1 Therapeutics, Inc. (GTHX) | 01-Jul-24 | Grant | 105,000 | -- | -- | 23% 452.34K to 557.34K | |
| 03-Jul-24 5:26 PM View: | Avagliano Mark Chief Business Officer | G1 Therapeutics, Inc. (GTHX) | 01-Jul-24 | Grant | 35,000 | -- | -- | 17% 209.68K to 244.68K | |
| 03-Jul-24 5:24 PM View: | Umstead John V. Chief Financial Officer | G1 Therapeutics, Inc. (GTHX) | 01-Jul-24 | Grant | 35,000 | -- | -- | 23% 153.25K to 188.25K | |
| 03-Jul-24 5:34 PM View: | Perry Andrew Chief Commercial Officer | G1 Therapeutics, Inc. (GTHX) | 01-Jul-24 | Grant | 35,000 | -- | -- | 44% 78.95K to 113.95K | |
| 14-Jun-24 4:42 PM View: | Secor Alicia Director | G1 Therapeutics, Inc. (GTHX) | 13-Jun-24 | Grant | 10,000 | -- | -- | 50% 20.0K to 30.0K | |
| 14-Jun-24 4:43 PM View: | Sharpless Norman Director | G1 Therapeutics, Inc. (GTHX) | 13-Jun-24 | Grant | 10,000 | -- | -- | 100% 10.0K to 20.0K | |
| 14-Jun-24 4:39 PM View: | Schwalm Cynthia Director | G1 Therapeutics, Inc. (GTHX) | 13-Jun-24 | Grant | 10,000 | -- | -- | 39% 25.89K to 35.89K | |
| 14-Jun-24 4:37 PM View: | Nicholson Garry A Director | G1 Therapeutics, Inc. (GTHX) | 13-Jun-24 | Grant | 10,000 | -- | -- | 41% 24.39K to 34.39K | |
| 14-Jun-24 4:40 PM View: | Lee Jacks Director | G1 Therapeutics, Inc. (GTHX) | 13-Jun-24 | Grant | 10,000 | -- | -- | 100% 10.0K to 20.0K | |
| 14-Jun-24 4:41 PM View: | Muir Glenn P Director | G1 Therapeutics, Inc. (GTHX) | 13-Jun-24 | Grant | 10,000 | -- | -- | 5% 195.36K to 205.36K | |
| 24-May-24 4:15 PM View: | Thomas Monica R. Chief Legal & People Officer | G1 Therapeutics, Inc. (GTHX) | 23-May-24 | Sale | 5,826 | $4.27 | $24,864.20 | (5%) 115.65K to 109.83K | |
| 15-May-24 4:06 PM View: | Bailey John E. (jack) Jr. President and CEO Director | G1 Therapeutics, Inc. (GTHX) | 13-May-24 | Sale | 37,258 | $4.79 | $178,421.00 | (8%) 489.59K to 452.34K |
